Washington Trust Advisors’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-197
Closed -$18.5K – 587
2025
Q3
$18.5K Buy
197
+23
+13% +$2.14K ﹤0.01% 449
2025
Q2
$15.1K Hold
174
– – ﹤0.01% 427
2025
Q1
$13.4K Hold
174
– – ﹤0.01% 436
2024
Q4
$16.8K Hold
174
– – ﹤0.01% 421
2024
Q3
$16.5K Buy
174
+16
+10% +$1.4K ﹤0.01% 424
2024
Q2
$13.2K Hold
158
– – ﹤0.01% 434
2024
Q1
$13.6K Hold
158
– – ﹤0.01% 441
2023
Q4
$13.1K Hold
158
– – ﹤0.01% 441
2023
Q3
$11.4K Hold
158
– – ﹤0.01% 444
2023
Q2
$12K Hold
158
– – ﹤0.01% 435
2023
Q1
$9.97K Hold
158
– – ﹤0.01% 501
2022
Q4
$8.59K Hold
158
– – ﹤0.01% 521
2022
Q3
$9K Hold
158
– – ﹤0.01% 613
2022
Q2
$7K Hold
158
– – ﹤0.01% 680
2022
Q1
$9K Hold
158
– – ﹤0.01% 715
2021
Q4
$8K Buy
+158
New +$8.45K ﹤0.01% 757

Other funds holding ACA

Washington Trust Advisors's ACA Position: Q4 2025 in Review

Washington Trust Advisors sold out of Arcosa (ACA) in Q4 2025, closing a stake of 197 shares — an estimated $18.5K sold.

Washington Trust Advisors first reported a position in ACA in Q4 2021 and held it in 16 quarters. The position peaked at $18.5K in Q3 2025. 365 funds tracked by Wall St. Rank hold ACA as of Q4 2025.

  • Washington Trust Advisors reported no remaining Arcosa position as of Q4 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 197 Arcosa shares in Q4 2025, an estimated $18.5K.
  • Washington Trust Advisors first reported a position in Arcosa in Q4 2021 and held it in 16 quarters.
  • Washington Trust Advisors's Arcosa position peaked at $18.5K in Q3 2025.
  • 365 funds tracked by Wall St. Rank held Arcosa as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.